z-logo
open-access-imgOpen Access
Inhibition of nuclear factor κB by prostaglandin A1: An effect associated with heat shock transcription factor activation
Author(s) -
Antônio Rossi,
Giuliano Elia,
M. Gabriella Santoro
Publication year - 1997
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.94.2.746
Subject(s) - heat shock factor , transcription factor , biology , heat shock , heat shock protein , chloramphenicol acetyltransferase , nf κb , iκbα , microbiology and biotechnology , nfkb1 , transfection , transcription (linguistics) , hsp70 , signal transduction , gene expression , biochemistry , promoter , gene , linguistics , philosophy
Prostaglandins (PGs) function as intracellular signal mediators in the regulation of a variety of physiological and pathological processes, including inflammation and immune responses. Cyclopentenone PGs are characterized by antiviral activity against several viruses, including human immunodeficiency virus type 1 (HIV-1), and by the ability to induce heat shock protein expression through activation of the heat shock transcription factor. Here we report that PGA1 is a potent inhibitor of nuclear factor-κB (NF-κB) activation in human cells and of NF-κB-dependent HIV-1 transcription in long terminal repeat-chloramphenicol acetyltransferase transient transfection experiments. PGA1 acts by inhibiting phosphorylation and preventing degradation of the NF-κB inhibitor IκB-α. Inhibition does not require protein synthesis, is dependent on the presence of a reactive cyclopentenonic moiety, and is associated with heat shock transcription factor activation. Because NF-κB is critically involved in the activation of immunoregulatory and viral genes, inhibition of its activity could be a major component of the immunosuppressive and antiviral activity of PGs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here